Recent studies have found that Ozempic could lead to more muscle mass loss than traditional weight loss methods.

Researchers at the University of Copenhagen have developed a new weight-loss drug that may surpass the effectiveness of Ozempic. This new drug stimulates calorie burning and reduces appetite without causing nausea,

The blockbuster GLP-1 drug semaglutide (Ozempic, Wegovy) could curb drinking for people battling alcohol use disorder, helping them to avoid crises that require hospitalization, new research shows. Numerous studies had already hinted that semaglutide might act on appetite centers in the brain to suppress the urge to drink,

The blockbuster drugs Ozempic and Wegovy may help people cut back on drinking, new research published Wednesday in JAMA Psychiatry suggests.

Another day, another study linking Ozempic to major health benefits. In fact, they found it to work even better than the current most-effective drug for treating alcoholism on the market. Syda Productions – stock.